Dispensing specialty-lite products through the retail channel can often limit life sciences organizations’ visibility into the patient journey. This pathway can also reduce opportunities to connect patients to support programs, as many specialty pharmacies are familiar with supporting these programs and processes while retail pharmacies are not.
In this Drug Channels Institute article, Vice President of Customer Success, Timothy Nielsen, discusses the affordability and patient journey challenges of specialty-lite products for patients, manufacturers and healthcare providers. He also highlights the innovative patient support program models life sciences organizations can utilize to overcome these challenges.
Drug Channels Institute is one of the industry’s leading publications offering expert insights on pharmaceutical economics and the drug distribution systems.